[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100606920":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":19,"centralContacts":26,"locations":36,"responsibleParty":54,"collaborators":10,"id":56,"slug":57,"hasResults":58,"nctId":59,"briefTitle":60,"officialTitle":60,"acronym":61,"eligibilityCriteria":62,"healthyVolunteers":58,"sex":63,"minAge":64,"maxAge":10,"enrollmentInfo":65,"targetDuration":10,"studyType":68,"phases":10,"briefSummary":69,"conditions":70,"keywords":72,"overallStatus":38,"whyStopped":10,"lastUpdateSubmitDate":78,"lastUpdatePostDateStruct":79,"startDateStruct":82,"completionDateStruct":84,"leadSponsor":86,"locationsCount":87},{"fullName":5,"class":6},"Centre Hospitalier Sud Francilien","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"VAP suspicion",null,"Adult patients (\\>18 years) under mechanical ventilation for \\>48 hours and with a positive respiratory sample",[13],"Other: Diagnostic tedst",[15],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":10},"Diagnostic tedst","* Radiologic signs: 2 consecutive thorax x-ray with new onset pneumonia AND\n* One of the following criteria\n\n  * Fever \\>38,3°C without any other cause\n  * Leucocytes \\\u003C 4000\u002Fmm3 or ≥ 12000 \u002Fmm3\n* AND at least two of the following\n\n  * Purulent secretions\n  * Cough or dyspnoea\n  * Desaturation or increase in FiO2 (+20%)",[9],[20,23],{"name":21,"affiliation":5,"role":22},"Luis ENSENYAT MARTIN, MD","PRINCIPAL_INVESTIGATOR",{"name":24,"affiliation":5,"role":25},"Abdoul DINE","STUDY_DIRECTOR",[27,32],{"name":21,"role":28,"phone":29,"phoneExt":30,"email":31},"CONTACT","33 1 61 69 31 57","+33","luis.ensenyatmartin@chsf.fr",{"name":33,"role":28,"phone":34,"phoneExt":30,"email":35},"Caroline TOURTE","33 1 61 69 31 50","caroline.tourte@chsf.fr",[37],{"facility":5,"status":38,"city":39,"state":40,"zip":41,"country":40,"countryCode":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":49},"RECRUITING","Corbeil-Essonnes","France","91100","FR",{"type":44,"coordinates":45},"Point",[46,47],2.48757,48.60603,{"lat":47,"lon":46},[50,52],{"name":21,"role":28,"phone":29,"phoneExt":51,"email":31},"33",{"name":24,"role":28,"phone":29,"phoneExt":51,"email":53},"abdl_dine@hotmail.fr",{"type":55,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100606920","vap-incidence-and-adequation-to-srlf-2017-diagnostic-among-an-intensive-care-medicine-service-for-the-period-2022--2024-100606920",false,"NCT07181824","VAP Incidence and Adequation to SRLF 2017 Diagnostic Among an Intensive Care Medicine Service for the Period 2022 à 2024","PAVM-RéaCHSF","Inclusion Criteria:\n\n* Adults ≥ 18 years\n* Hospitalization in Intensive care unit for the period between 01\u002F01\u002F2022 and 31\u002F12\u002F2024\n* Intubation and mechanical ventilation for \\> 48h\n* Positive respiratory sample\n\nExclusion Criteria:\n\n* Decision of therapeutic limitation\n* Organ donors\n* Patient refuse to participate","ALL","18 Years",{"count":66,"type":67},100,"ESTIMATED","OBSERVATIONAL","The goal of this observational study is to to analyze respiratory samples performed in mechanically ventilated ICU patients and to assess whether the SRLF criteria for defining VAP were respected among patients admited to the Intensive care medicine at a regional hospital en France",[71],"Pneumonia Ventilator Associated",[73,74,75,76,77],"Ventilatory associated pneumonia","VAP","Intensive Care medicine","Mechanical ventilation","Pneumonia","2025-12-08",{"date":80,"type":81},"2025-12-09","ACTUAL",{"date":83,"type":81},"2025-08-25",{"date":85,"type":67},"2026-06-30",{"name":5,"class":6},1]